{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:07:29Z","timestamp":1773266849102,"version":"3.50.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017053","name":"NSFC-Xinjiang Joint Fund","doi-asserted-by":"publisher","award":["81760331"],"award-info":[{"award-number":["81760331"]}],"id":[{"id":"10.13039\/100017053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> To explore a CT-based radiomics model for preoperative prediction of event-free survival (EFS) in patients with hepatoblastoma and to compare its performance with that of a clinicopathologic model.<\/jats:p><jats:p><jats:bold>Patients and Methods:<\/jats:bold> Eighty-eight patients with histologically confirmed hepatoblastoma (mean age: 2.28 \u00b1 2.72 years) were recruited from two institutions between 2002 and 2019 for this retrospective study. They were divided into a training cohort (65 patients from institution A) and a validation cohort (23 patients from institution B). Radiomics features were extracted manually from pretreatment CT images in the portal venous (PV) phase. The least absolute shrinkage and selection operator (LASSO) Cox regression model was applied to construct a \u201cradiomics signature\u201d and radiomics score (Rad-score) for EFS prediction. Then, a nomogram incorporating the Rad-score, updated staging system, and significant variables of clinicopathologic risk (age, alpha-fetoprotein (AFP) level, histology subtype, tumor diameter) as the radiomic model, clinicopathologic model, and combined clinicopathologic-radiomic model were built for EFS estimation in the training cohort, the performance of which was assessed in an external-validation cohort with respect to clinical usefulness, discrimination, and calibration.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Nine survival-relevant features were selected for a radiomics signature and Rad-score building. Multivariable analysis revealed that histology subtype (<jats:italic>P<\/jats:italic> = 0.01), PV (<jats:italic>P<\/jats:italic> = 0.001) invasion, and metastasis (<jats:italic>P<\/jats:italic> = 0.047) were independent risk factors of EFS. Patients were divided into low- and high-risk groups based on the Rad-score with a cutoff of 0.08 according to survival outcome. The radiomics signature-incorporated nomogram showed good performance (<jats:italic>P<\/jats:italic> &amp;lt; 0.001) for EFS estimation (C-Index: 0.810; 95% CI: 0.738\u20130.882), which was comparable with that of the clinicopathological model for EFS estimation (C-Index: 0.81 vs. 0.85). The radiomics-based nomogram failed to show incremental prognostic value compared with that using the clinicopathologic model. The combined model (radiomics signature plus clinicopathologic parameters) showed significant improvement in the discriminatory accuracy, along with good calibration and greater net clinical benefit, of EFS (C-Index: 0.88; 95% CI: 0.829\u20130.933).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The radiomics signature can be used as a prognostic indicator for EFS in patients with hepatoblastoma. A combination of the radiomics signature and clinicopathologic risk factors showed better performance in terms of EFS prediction in patients with hepatoblastoma, which enabled precise clinical decision-making.<\/jats:p>","DOI":"10.3389\/fonc.2021.644994","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T20:06:28Z","timestamp":1618603588000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Preoperative Assessment for Event-Free Survival With Hepatoblastoma in Pediatric Patients by Developing a CT-Based Radiomics Model"],"prefix":"10.3389","volume":"11","author":[{"given":"Yi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linjun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingkun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1053\/jhep.2003.50375","article-title":"Epidemiology of primary hepatic malignancies in U.S. children","volume":"38","author":"Darbari","year":"2003","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40880-019-0411-7","article-title":"Incidence trends and survival prediction of hepatoblastoma in children: a population-based study","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3978\/j.issn.2224-4336.2014.09.01","article-title":"Pediatric hepatoblastoma: diagnosis and treatment","volume":"3","author":"Hiyama","year":"2014","journal-title":"Transl Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","article-title":"Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.17116\/hirurgia20171270-74","article-title":"Surgical treatment of hepatoblastoma PRETEXT\/POST-TEXT III and IV","volume":"12","author":"Kim","year":"2017","journal-title":"Khirurgiia."},{"key":"B6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MOP.0000000000000046","article-title":"Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy","volume":"26","author":"Czauderna","year":"2014","journal-title":"Curr Opin Pediatr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e28350","DOI":"10.1002\/pbc.28350","article-title":"The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: analysis from the Children's Hepatic tumors Inte rnational Collaboration (CHIC) database","volume":"67","author":"Haeberle","year":"2020","journal-title":"Pediatric Blood Cancer."},{"key":"B8","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","article-title":"Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study","volume":"14","author":"Zsiros","year":"2013","journal-title":"Lancet Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/pbc.22088","article-title":"Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group","volume":"53","author":"Meyers","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1200\/JCO.2005.07.145","article-title":"Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study","volume":"23","author":"Aronson","year":"2005","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.ejca.2011.12.011","article-title":"Prognostic stratification for children with hepatoblastoma: the SIOPEL experience","volume":"48","author":"Maibach","year":"2012","journal-title":"Eur J Cancer."},{"key":"B12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/cncr.10632","article-title":"Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94","volume":"95","author":"Fuchs","year":"2002","journal-title":"Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","article-title":"The Children's Hepatic tumors International Collaboration (CHIC): novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model","volume":"52","author":"Czauderna","year":"2016","journal-title":"Eur J Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/MOP.0000000000000042","article-title":"Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation","volume":"26","author":"Meyers","year":"2014","journal-title":"Curr Opin Pediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s00247-018-4078-z","article-title":"2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT)","volume":"48","author":"Towbin","year":"2018","journal-title":"Pediatr Radiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S1470-2045(16)30579-4","article-title":"A common global risk stratification system for hepatoblastoma","volume":"18","author":"Shaikh","year":"2017","journal-title":"Lancet Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s00247-018-4162-4","article-title":"Staging and following common pediatric malignancies: MRI versus CT versus functional imaging","volume":"48","author":"Voss","year":"2018","journal-title":"Pediatr Radiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"11707","DOI":"10.7150\/thno.50565","article-title":"Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"820","DOI":"10.21037\/atm-19-4668","article-title":"Radiomics predict postoperative survival of patients with primary liver cancer with different pathological types","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann Transl Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1002\/jmri.27289","article-title":"Preoperative assessment for high-risk endometrial cancer by developing an MRI- and clinical-based radiomics nomogram: a multicenter study","volume":"52","author":"Yan","year":"2020","journal-title":"J Magn Reson Imaging."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.7150\/thno.37429","article-title":"Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer","volume":"10","author":"Fang","year":"2020","journal-title":"Theranostics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ctm2.31","article-title":"Prognostic and predictive value of radiomics signatures in stage I-III colon cancer","volume":"10","author":"Dai","year":"2020","journal-title":"Clin Transl Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.21037\/tlcr-19-577","article-title":"Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma","volume":"9","author":"Xie","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1148\/radiol.2016152234","article-title":"Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer","volume":"281","author":"Huang","year":"2016","journal-title":"Radiology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clinimag.2017.03.023","article-title":"Contrast-enhanced CT features of hepatoblastoma: can we predict histopathology?","volume":"44","author":"Baheti","year":"2017","journal-title":"Clin Imaging"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3390\/cancers11091387","article-title":"Prognostic factors for event-free survival in pediatric patients with hepatoblastoma based on the 2017 PRETEXT and CHIC-HS systems","volume":"11","author":"Yoon","year":"2019","journal-title":"Cancers"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/S0959-8049(00)00074-5","article-title":"Pretreatment prognostic factors for children with hepatoblastoma\u2013 results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1","volume":"36","author":"Brown","year":"2000","journal-title":"Eur J Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/modpathol.2013.80","article-title":"Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium","volume":"27","author":"L\u00f3pez-Terrada","year":"2014","journal-title":"Mod Pathol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1007\/s00330-020-06872-z","article-title":"Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics","volume":"30","author":"Choe","year":"2020","journal-title":"Eur Radiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ctrv.2019.06.002","article-title":"The role of PET\/CT in the modern treatment of Hodgkin lymphoma","volume":"77","author":"Zaucha","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1158\/1078-0432.CCR-18-2861","article-title":"Radiomics on gadoxetic acid-enhanced magnetic resonance imaging for prediction of postoperative early and late recurrence of single hepatocellular carcinoma","volume":"25","author":"Kim","year":"2019","journal-title":"Clin Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ebiom.2018.09.007","article-title":"Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer","volume":"36","author":"Jiang","year":"2018","journal-title":"EBioMedicine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/hep.27877","article-title":"A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma","volume":"62","author":"Banerjee","year":"2015","journal-title":"Hepatology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1148\/radiol.13132195","article-title":"Behind the numbers: decoding molecular phenotypes with radiogenomics-guiding principles and technical considerations","volume":"270","author":"Kuo","year":"2014","journal-title":"Radiology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1038\/ncomms5644","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"key":"B38","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1200\/JCO.2011.39.2316","article-title":"Cancer genomics: technology, discovery, and translation","volume":"30","author":"Tran","year":"2012","journal-title":"J Clin Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1200\/JCO.2010.29.3837","article-title":"Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group","volume":"29","author":"Malogolowkin","year":"2011","journal-title":"J Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.12688\/f1000research.12239.1","article-title":"Hepatoblastoma: current understanding, recent advances, and controversies","volume":"7","author":"Czauderna","year":"2018","journal-title":"F1000Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.clinimag.2018.08.009","article-title":"Diagnosis, histopathologic correlation and management of hepatoblastoma: what the radiologist needs to know","volume":"52","author":"Baheti","year":"2018","journal-title":"Clin Imaging"},{"key":"B42","doi-asserted-by":"publisher","first-page":"djv291","DOI":"10.1093\/jnci\/djv291","article-title":"Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma","volume":"108","author":"Tang","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"B43","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/SLA.0000000000001339","article-title":"Nomograms for pre- and postoperative prediction of long-term survival for patients who underwent hepa tectomy for multiple hepatocellular carcinomas","volume":"263","author":"Yang","year":"2016","journal-title":"Ann Surg"},{"key":"B44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.radonc.2020.06.004","article-title":"Integrating tumor and nodal radiomics to predict lymph node metastasis in gastric cancer","volume":"150","author":"Yang","year":"2020","journal-title":"Radiother Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.644994\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T20:06:32Z","timestamp":1618603592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.644994\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":44,"alternative-id":["10.3389\/fonc.2021.644994"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.644994","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,16]]},"article-number":"644994"}}